$0.7295
-0.0022-0.3%
Last update: Nov 6, 12:48 PM
Connect Biopharma Holdings Ltd
CNTBNASDAQ
The average analyst price target for Connect Biopharma Hldgs is $6.11, 737.6% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $4 to $9. The latest change came on Oct 12, 2026, when Leerink Partners assumed coverage of Connect Biopharma Hldgs with an Outperform rating and a $4 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
